Once-Daily Venlafaxine Extended Release (XR) and Venlafaxine Immediate Release (IR) in Outpatients with Major Depression

References

• Muth EA, Haskins JT, Moyer JA, et al.: Antidepressant bio-chemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986; 35: 4493–4497.
   Google Scholar
• Benkert 0, GT-Linder G, Wetzel, H, et al.: A randomized, dou-ble-blind comparison of a rapidly escalating dose of venlafax-Me and imipramine in inpatients with major depression and melancholia. J Psychiatr Res 1996; 30: 441–451
   Google Scholar
• Clerc GE, Ruimy P, Verdeau-Pailles J: A double-blind com-parison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychophanna-col 1994; 9:138–143.
   Google Scholar
• Cunningham LA, Borison RL, Carman JS, et al.: A compari-son of venlafaxine, trazodone, and placebo in major depres-sion. J Clin Psychopharmacol 1994; 14:99–106.
   Google Scholar
• Dierick M, Ravizza L, Realini R, et al.: A double-blind com-parison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Prog Neuropsychophannacol Biol Psychiatry 1996; 20:57–71.
   Google Scholar
• Lecrubier Y, Moon CAL, Schifano F, et al.: Double-blind, ran-domized, placebo-controlled comparison of venlafaxine and imipramine in general practice patients with mild to moderate depression. Acta Psychiatr Scand 1997; 95:485–493
   Google Scholar
• Rudolph R, Feighner J, Riekels K: A double-blind, random-ized, placebo-controlled trial of venlafaxine in outpatients with major depression. J Clin Psychiatry 1997 (in press)
   Google Scholar
• Schweizer E, Feighner J, Mandos L, et cd.: Comparison of yen-lafaxine and imipramine in the acute treatment of major de-pression in outpatients. J Clin Psychiatry 1994; 55:104–108
   Google Scholar
• Shrivastava R, Cohn C, Crowder J, et cd.: Long-term safety and clinical acceptability of venlafaxine and imipramine in out-patients with major depression. J Clin Psychopharmacol 1994; 14:322–329
   Google Scholar
• Tylee A, Bowden M, Reynolds A, et al. A double-blind, ran-domized, 12-week comparison study of the safety and effi-ciency of venlafaxine and fluoxetine 20 mg in moderate to severe depression in general practice. Primary Care Psychiatry 1997; 3:51–58
   Google Scholar
• Holliday SM, Benfield P. Venlafaxine: A review of its phar-macology and therapeutic potential in depression. Drugs 1995; 49:280–294
   PubMed Web of Science ®Google Scholar
• Hamilton MA: A rating scale for depression. J Neurol Neuro-surg Psychiatry 1960; 23:56–62
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382–389
   PubMed Web of Science ®Google Scholar
• Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. DHEW Pub. No. (ADM)76-338. Rockville, MD: Na-tional Institutes of Mental Health, 1976
   Google Scholar
• Entsuah R, Upton GV, Rudolph R. Efficacy of venlafaxine treatment in depressed patients with psychomotor retardation or agitation: A meta-analysis. Hum Psychopharmacol 1995; 10:195–200
   Google Scholar
• Guelfi JD, White C, Hackett D, et al.: Effectiveness of venla-faxine in patients hospitalized with major depression and mel-ancholia. J Clin Psychiatry 1995; 56:450–458
   Google Scholar
• Khan A, Rudolph R, Baumel B, et al.: Venlafaxine in de-pressed geriatric outpatients: An open-label clinical study. Psy-chopharmacol Bull 1995; 31:753–758
   Google Scholar
• Michels R, Marzuk PM: Progress in psychiatry. N Engl J Med 1993; 329:628–638
   PubMed Web of Science ®Google Scholar
• Potter WZ, Rudorfer MV, Manji H. The pharmacologic treat-ment of depression. N Eng .1 Med 1991; 325:633–642
   Google Scholar
• Preskorn SH, Janicak PG, Davis JM, et al.: Advances in the pharmacotherapy of depressive disorders. In: Janicak PG, Davis JM, Preskom SH, Ayd FJ Jr, eds. Principles and Practice of Psychopharmacotherapy, Vol. 1, No. 2. Baltimore: Williams and Wilkins; 1995
   Google Scholar
• Ereshefsky L: Drug-drug interactions involving antidepres-sants: Focus on venlafaxine. J Clin Psychopharmacol 1996; 16 (Suppl 2):37S–53S
   Google Scholar
• Ferguson J, Khan A, Kucharik R, et al.: A placebo-controlled comparative study of the effects of blood pressure and anti-depressant efficacy of venlafaxine and imipramine. Neuropsy-chophannacology 1994; 10:117 (abstract)
   Google Scholar